Press Release

  • Grand News Network
  • November 6, 2023

Sarepta Therapeutics President & CEO Makes $2.00M Stock Purchase


Douglas S Ingram, President & CEO at Sarepta Therapeutics (NASDAQ:SRPT), reported a large insider buy on November 6, according to a new SEC filing.

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Ingram purchased 25,225 shares of Sarepta Therapeutics. The total transaction amounted to $2,001,799.

Sarepta Therapeutics shares are trading up 3.87% at $81.03 at the time of this writing on Monday morning.

Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.

Why Insider Transactions Are Important

Insider transactions shouldn't be used primarily to make an investing decision, ...

Full story available on Benzinga.com


Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.


Disclaimer Press Release Banner

Cryptocurrency Rates

More to read